Sign in
Active, not recruitingNo phase

Assessment of DOT Spectacles in Chinese Children Extension

Key facts

Who runs it
SightGlass Vision, Inc.
Where
China5 sites in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
175 people, planned
Started
1 Aug 2025
Expected to end
30 Jun 2027
Type of study
Interventional, 2 groups
Treatments tested
  • Novel spectacle lens design
Record updated
17 November 2026

Who can take part

Age
8 years to 16 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Previously a successfully completed participant in the CATHAY study (NCT05562622)
  • Agree to wear the assigned spectacles constantly except for sleeping, swimming, or other activities in which spectacle wear would be dangerous or otherwise not possible (minimum of 10 hours per day)
  • Willingness to participate in the trial for 12 months without contact lens wear or any other myopia management intervention
  • The subject's parent(s) or legal guardian(s) must read, understand and sign the Statement of Informed Consent and receive a fully executed copy of the form

Who cannot take part

  • Known allergy to proparacaine, tetracaine, or tropicamide or cyclopentolate

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This is a randomized, controlled, open-label, evaluator-blinded, multicenter, clinical trial of 12-months duration to evaluate the continued safety and efficacy of Diffusion Optics Technology (DOT) spectacle lenses in reducing the progression of juvenile myopia in children of Chinese origin.

The 2 groups in the trial

  • SightGlass Vision Test Arm Groups I (formerly test group)Treatment being tested

    Single vision, impact-resistant spectacle lenses

    Treatment: Novel spectacle lens design

  • SightGlass Vision Test Arm Groups II (formerly control group)Treatment being tested

    Single vision, impact-resistant spectacle lenses

    Treatment: Novel spectacle lens design

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Clinical Assessment of DOT Spectacle Lenses in Chinese Children Extension
Record updated
17 November 2026